v3.26.1
Note 19 - Subsequent Events
3 Months Ended
Mar. 31, 2026
Notes to Financial Statements  
Subsequent Events [Text Block]

19.

Subsequent Events

 

Amendments to Articles of Incorporation

 

On April 22, 2026, Valion Bio, Inc. filed a certificate of amendment ("Certificate of Amendment”) to its amended and restated certificate of incorporation filed with the Delaware Secretary of State to change its corporate name from Tivic Health Systems, Inc. to Valion Bio, Inc. (the "Name Change”), effective as of April 28, 2026. Pursuant to Delaware law, a shareholder vote was not necessary to effectuate the Name Change and it does not affect the rights of the Company’s shareholders. Additionally, the Company's common stock, par value $0.0001 per share, ceased trading under the ticker symbol ‘TIVC’ and began trading under its new ticker symbol ‘VBIO’ on The Nasdaq Capital Market LLC effective April 28, 2026.